New Markers of Aortic Stenosis Define Asymptomatic Patients

Asymptomatic aortic stenosis has been keeping us in tense stillness. However, there are new markers capable of identifying patients that might benefit from earlier intervention. In this regard, cardiovascular magnetic resonance (CMR) has been gaining its well-deserved place in cardiology and now more specifically in aortic stenosis. 

Nuevos marcadores de daño en estenosis aórtica que definen pacientes asintomáticos

This study sought to validate CMR markers of prognostic value to aortic stenosis and its thresholds to predict mortality.   

The study prospectively included 799 aortic stenosis patients (n=440 in the derivation cohort and n=359 in the validation cohort) from 13 international centers followed up for nearly 4 years. 

CMR was done shortly before surgical or transcatheter aortic valve replacement (AVR). A forest model was used with 29 variables (13 CMR) capable of predicting mortality and post procedure events. 

There were 52 deaths in the derivation cohort and 51 deaths in the validation cohort. The 4 CMR markers with most predictive power were extracellular volume fraction, late gadolinium enhancement, indexed left ventricular end-diastolic volume, and right ventricular ejection fraction.  

Mortality increased significantly both in the global cohort and among asymptomatic patients when extracellular volume fraction exceeded 27%. 2% of late gadolinium enhancement showed persistent high risk. 


Read also: Anticoagulation with Heparin in Non-Critical COVID-19.


As regards indexed left ventricular end-diastolic volume, increased mortality was also observed at both extremes. High (>80 ml/m2) and low volumes (<55 ml/m2) were mortality predictors.  

There was also increased mortality with high (>80%) and low (≤50%) right ventricular ejection fraction (>80% y <50%).

Predictability improved even further when these 4 markers were combined with clinical factors 


Read also: Heparin Anticoagulation in Critically Ill COVID-19 Patients: Results that Differ from the Rest.


The prognostic thresholds and risk stratification by CMR variables were reproduced in the validation cohort. 

Conclusion

Myocardial fibrosis and biventricular remodeling are the best prognostic factors in patients with aortic stenosis. We should highlight its non-linear association with mortality. 

CMR has the potential to optimize decision making in treating patients with aortic stenosis. 

Original Title: Markers of Myocardial Damage Predict Mortality in Patients With Aortic Stenosis.

Reference: Soongu Kwak et al. J Am Coll Cardiol. 2021 Aug 10;78(6):545-558. doi: 10.1016/j.jacc.2021.05.047.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Management of Valve Thrombosis in TAVI: Current Evidence-Based Approach

The expansion of transcatheter aortic valve implantation (TAVI) into younger and lower-risk populations has brought bioprosthetic valve thrombosis to the forefront as a clinically...

Experience with the intra-annular self-expanding Navitor valve: data from the STS/ACC TVT registry

The expansion of TAVI, with the introduction of new-generation devices, has prioritized not only periprocedural safety, but also the preservation of coronary access, more...

The Two Sides of the Coin: What Do CHAMPION-AF and CLOSURE-AF Teach Us About Left Atrial Appendage Closure?

Letter to the editor: Juan Manuel Pérez Asorey Percutaneous left atrial appendage closure (LAAO) is currently going through one of the most interesting stages of...

CLOSURE-AF: Percutaneous Left Atrial Appendage Closure versus Medical Therapy in Atrial Fibrillation

Percutaneous left atrial appendage closure has been proposed as an alternative to anticoagulation in patients with atrial fibrillation and high bleeding risk; however, comparative...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

High Ischaemic Risk Criteria in Chronic Coronary Syndrome: Prevalence and Prognosis

Despite advances in the management of chronic coronary syndrome (CCS), including the widespread use of drug-eluting stents (DES) and the optimization of medical therapy,...

Management of Valve Thrombosis in TAVI: Current Evidence-Based Approach

The expansion of transcatheter aortic valve implantation (TAVI) into younger and lower-risk populations has brought bioprosthetic valve thrombosis to the forefront as a clinically...

Experience with the intra-annular self-expanding Navitor valve: data from the STS/ACC TVT registry

The expansion of TAVI, with the introduction of new-generation devices, has prioritized not only periprocedural safety, but also the preservation of coronary access, more...